Portfolio company
Aclid
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Aclid provides an automated biosecurity and compliance platform for gene synthesis providers and synthetic biology research institutions to screen DNA sequences and verify customers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genome Compiler
This company provides a software platform for genetic engineering and synthetic biology, allowing scientists to design, manage and order DNA sequences.
Seed, 2024
This company develops a single-molecule DNA sequencing platform for clinical diagnostics, agriculture, and biosecurity sectors.
Evonetix
The company develops a desktop DNA synthesis platform for researchers in synthetic biology and drug development to produce high-fidelity gene sequences.
Claryx
Claryx develops a genomic surveillance platform that sequences pathogen DNA to detect and trace infection outbreaks for hospitals and healthcare systems.
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
Clearlabs
This company develops automated next-generation sequencing platforms for food safety testing and clinical diagnostics for food brands and laboratories.
Open Protein
This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.
Elegen
The company manufactures synthetic DNA using cell-free technology for biopharmaceutical and healthcare customers to develop vaccines and genetic medicines.
